Previous 10 |
home / stock / inno:cc / inno:cc news
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 11, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to report the "accepted for publication" of a Case Report Article describing subcutaneously injected liposomal ca...
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 28, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), is pleased to report the successful completion of Innocan's CBD Liposome drug-product physico-chemical characterization. Phy...
News, Short Squeeze, Breakout and More Instantly...
Innocan Pharma Corporation - Common Shares Company Name:
INNO:CC Stock Symbol:
CNQC Market:
Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs Canada NewsWire HERZLIYA, Israel and CALGARY, AB , June 11, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a...
Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million Canada NewsWire HERZLIYA, Israel and CALGARY, AB , May 27, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan...
FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain Canada NewsWire The regulatory approval process with the U.S. Food and Drug Administration has commenced for Innocan's LPT-CBD release technology, marking a key step in the advancement of non-opioid pai...